[Everolimus inhibits malignant phenotype of erdafitinib-resistant bladder cancer cells through the p70S6K/PI3K/MAPK signaling pathway].
Aug 2026 · Nan fang yi ke da xue xue bao = Journal of Southern Medical University · Vol 46 8, pp.
1870-1877
· 0 citations
Medicine